VISITAG SURPOINT™ Module (also known as VISITAG with Ablation Index)
VISITAG SURPOINT™ Module (also known as VISITAG with Ablation Index)
By providing a built-in algorithm and standard workflow, VISITAG SURPOINT™ Module allows EPs to focus on a single value – the Ablation Index – which represents stability, power, contact force, and time. With VISITAG SURPOINT™ Module, EPs can reproduce their own successful ablation strategy in a standard and simple1*.
MEDIA
By providing a built-in algorithm and standard workflow, VISITAG SURPOINT™ Module allows EPs to focus on a single value – the Ablation Index – which represents stability, power, contact force, and time. With VISITAG SURPOINT™ Module, EPs can reproduce their own successful ablation strategy in a standard and simple1*.
Features & Benefits
Seamless Integration
- Seamless integration with VISITAG® Module tag visualisation
- Supported by scientific data, treating patients is more consistent
- EPs can manage a single number rather than having to focus on multiple data points
- Objective tag placement based on customised settings
- A single center study resulted in up to 92% single procedure success rate at 1 year follow-up1*
Resources
duyts_carto_1workflow-v4 090903-180427
10:03
duyts_carto_2summary-v3 090904-180427
07:53
Supporting Documentation
Request Sales Rep
If you wish to learn more about this product, submit a request and a representative of Biosense Webster will be in touch shortly.
Request Brochure
If you require a printed or digital brochure or surgical technique for this product, submit your request and we will send it to you.
Other Requests
Have a different kind of query? Simply fill out the details of your request and we will get back to you as soon as possible.
References
* Statement is based on a single center study.
- Taghji P, El Haddad M, Phlips T , et al Evaluation of a strategy aiming to enclose the pulmonary veins with contiguous and optimized radiofrequency lesions in paroxysmal atrial fibrillation . A pilot study. J Am Coll cardiol EP January 01, 2018, 4 (1) 99-108.
Indication Statement
Important information: For product details such as indications, contraindications, warnings and precautions please consult the IFU.
VISITAG SURPOINT™ Module (also known as VISITAG with Ablation Index) provides access to data collected during the application of RF energy. The data does not indicate the effectiveness of RF energy application. Refer to the CARTO™ 3 System Instructions for use and Optimum Device Performance Guide for proper recommendations and settings. Tag Index values can only be compared when created with the same VISITAG™ Module settings. The Tag Index values should not be used to replace standard handling precautions or other clinically accepted endpoints for RF applications such as reduction of IC signals, impedance drop, force, etc. Tag Index values do not represent clinical outcome.
116881-210929 EMEA
© Johnson & Johnson Medical NV/SA 2022. All rights reserved.
This site is published by Johnson & Johnson Medical NV/SA, which is solely responsible for its content.
This site is for visitors from Europe, Middle East and Africa.
The third party trademarks used herein are trademarks of their respective owners.
Please refer always to the Instructions for Use / Package Insert that come with the device for the most current and complete instructions.
